Over 100 Chinese companies produce antibodies

Dongxing Securities assumes that the Chinese market fo therapeutic antibodies can grow 10fold as soon as Chinese companies have acquired mature industrial antibody know-how including R&D, HTS, production technology and quality control.

China Bio news release October 9, 2013

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year. Accept or Deny